版本:
中国

BRIEF-Cynata Therapeutics initiates formal regulatory engagement for U.S. market

April 19 Cynata Therapeutics Ltd

* initiates formal regulatory engagement for us market

* Cynata expects to receive FDA's written advice arising from pre-ind meeting by July 2017.

* granted a pre-investigational new drug meeting with united states food and drug administration (FDA) office of cell, tissue and gene therapy products Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐